Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients At Nutritional Risk
1 other identifier
interventional
220
1 country
1
Brief Summary
Protein-calorie malnutrition is a frequent comorbidity in hospitalized patients and there is evidence that the nutritional status may influence the response to drug treatment, mortality, susceptibility to infections, the patient's functional status, duration of hospital stay and, consequently, overall healthcare costs. The causes of malnutrition are manifold. The underlying disease may in fact lead to an increase in the patient's energy needs, whether or not associated with a reduction in caloric intake. The same therapeutic treatments can further worsen the energy balance without considering that the patient can be kept fasting for the execution of some diagnostic procedures. Therefore, a further deterioration of nutritional status during hospitalization could occur. International guidelines underline the utility to set a nutritional support whenever this is necessary, not only to prevent or treat malnutrition but also improve clinical outcomes. In this perspective, the improvement of oral diet and the use of oral nutritional supplements (ONS) represent the first-line strategy of intervention. Previous studies have shown that nutritional counseling, with or without the use of ONS, in patients with chronic disease is able to improve the calorie-protein intake, prevent deterioration of nutritional status, as well as to increase to a certain extent body weight. Particularly, energy-dense are more effective in increase energy intake. These data have highlighted the importance of a proper evaluation of the nutritional status of early detection of patients who could benefit of nutritional support. However, the independent role of the ONS in improving clinical outcome still needs to be established.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2016
CompletedStudy Start
First participant enrolled
July 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedNovember 18, 2024
November 1, 2024
8 years
May 3, 2016
November 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Body composition
Change in phase angle as assessed by vectorial impedance analysis
7 days
Secondary Outcomes (9)
Body composition
14 days
Body composition
Hospital stay, an average of 17 days
Functional status
7 days
Functional status
14 days
Functional status
Hospital stay, an average of 17 days
- +4 more secondary outcomes
Study Arms (2)
Intensive nutritional counseling
EXPERIMENTALDietary counseling + energy dense oral nutritional supplements
Dietary counseling
ACTIVE COMPARATORDietary counseling
Interventions
Dietary counseling + energy-dense oral nutritional supplements since admission
Dietary counseling alone. In case of inadequate energy intake patients will receive oral nutritional supplements since day 8 from admission (after the evaluation of the primary end point)
Eligibility Criteria
You may qualify if:
- Nutritional Risk Score \[NRS-2002\] ≥3
- assessed within 48 hours since admission
- expected length of stay ≥7 days
- written informed consent
You may not qualify if:
- age \< 18 years
- ongoing or indication to artificial nutrition
- severe hypophagia (intake \<50% of estimated requirements)
- scheduled for surgery
- indication to fasting
- physician-based contra-indication to use of liquid oral nutritional supplements (vomitus, severe nausea, diarrhea, dysphagia)
- physician-based indication to the of disease-specific oral nutritional supplements (e.g. kidney failure or pressure ulcers)
- terminal illness
- unavailability to planned measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emanuele Ceredalead
Study Sites (1)
Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emanuele Cereda, MD, PhD
Fondazione IRCCS Policlinico San Matteo
- STUDY CHAIR
Riccardo Caccialanza, MD
Fondazione IRCCS Policlinico San Matteo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Fondazione IRCCS Policlinico San Matteo di Pavia
Study Record Dates
First Submitted
May 3, 2016
First Posted
May 5, 2016
Study Start
July 30, 2016
Primary Completion
July 24, 2024
Study Completion
July 30, 2024
Last Updated
November 18, 2024
Record last verified: 2024-11